Adir Et Compagnie

G Erard Adam

Pierre Renard

Daniel-Henri Caignard

Daniel Lesieur

Patrick Depreux

Philippe Delagrange

Marie-Claude Viaud

Michel Langlois

B Eatrice Guardiola-Lemaitre

G Erald Guillaumet

Bruno Pfeiffer

Said Yous

Daniel H Caignard

Sylvain Rault

Guillaume Le Baut

Marie-Claire Rettori

Jean-Guy Bizot-Espiard

Sylvie Robert-Piessard

Max Robba

Jean-Charles Lancelot

Hamid Ait Mansour

Muriel Duflos

Francedillaois Lefoulon

Lucien Welin

Herv E Prunier

Laurence Savelon

Panayota Pavli

The invention relates to a compound selected from those of formula (I): ##STR1## wherein R.sub.1, W and Y are as defined in the description, its geometric and/or optical useful as anti-algies.

1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and

The invention relates to a compound selected from those of general formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and R.sub.3 are as defined in the specification, an optical isomer, and an addition salt thereof with a pharmaceutically-acceptable base. Medicinal product which is useful in the treatment of disorders linked to abnormal melatonin activity.

Naphthylalkylamines

A compound which is selected from those of formula (I) : ##STR1## in which A, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined in the description, its optical isomers, and its addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful for treating a disorder of the melatoninergic system.

Arylalkyl (thio)amides

The present invention relates to a compound selected from these of formula (I): ##STR1## in which A and R.sub.1 are as defined in the description, and medicinal product containing the same which is useful for treating a disorder linked to the 5-HT.sub.3 receptors.

Tricyclic pyrrolopyrazine 5-HT.sub.3 -active compounds

Compounds of the general formula: ##STR1## wherein m, X, Y, A, R.sub.2 and R.sub.3 are defined in the description, and medicaments containing the same.

Alpha-amino acid compounds

The invention relates to a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.2', R.sub.2', R.sub.2'', R.sub.3 and n are as defined in the description, an optical isomer, and an addition salt thereof with a pharmaceutically-acceptable acid or base, and medicinal product containing the same useful for treating a mammal afflicted with a disorder associated to 5-HT.sub.1A or 5-HT.sub.2C receptors.

Alkylaminoindane compounds

A compound which is selected from those of formula (I): ##STR1## in which A, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined in the description,

Arylalkyl(thio) amides

The invention relates to a compound selected from those of formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and R.sub.3 are as defined in the specification, and a medicinal product containing said compound for treating a disorder of the melatoninergic system.

Trisubstituted Naphthylalkylamides

Growing community of inventors

Le Mesnil Le Roi, France

G Erard Adam